W63-31336-40184
3 vaccinations
2 coded responses
11 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 234 / VA
- Registered
- 2021-07-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-06
Dose 1 — Pfizer-BioNTech
-
2021-07-23
Registered in v-safe
- 2021-07-23
-
2021-07-27
Dose 2 — Pfizer-BioNTech
- 2021-08-03
- 2021-08-10
- 2021-08-17
- 2021-08-24
- 2021-08-31
- 2021-09-07
-
2021-10-26
Survey response — 3 months, dose 2MedDRA: Cough — Feeling: GoodFree text: Recurrent CoughMedDRA releases: 2024-11 · check-in free text available
- 2022-01-25
-
2022-01-27
Dose 3 — Pfizer-BioNTech
- 2022-07-28
-
2023-01-29
Survey response — 12 months, dose 3MedDRA: COVID-19, Cough, Fatigue, Nasopharyngitis, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-06 | Pfizer-BioNTech | No |
| 2 | 2021-07-27 | Pfizer-BioNTech | No |
| 3 | 2022-01-27 | Pfizer-BioNTech | No |
Free text
Release 10 — 3 months, dose 2
Symptoms: Recurrent Cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release